Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells

Karim Benabdellah1,2, Pilar Muñoz1, Marién Cobo1

  • 1Genomic Medicine Department. GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Goverment, Parque Tecnológico Ciencias de la Salud, Av. de la Ilustración 114, 18016 Granada, Spain.

Scientific Reports
|November 18, 2016
PubMed

Insights

We developed Lent-On-Plus, a novel Tet-On lentiviral vector system for precise control of gene expression in human stem cells. This system overcomes previous limitations, enabling efficient and stable transgene regulation in both multipotent and pluripotent stem cells.

Area of Science:

  • Stem cell biology
  • Gene therapy
  • Molecular biology

Background:

  • Conditional transgene expression in human stem cells is challenging due to inefficient delivery, transgene silencing, and regulator toxicity.
  • Existing Tet-On systems often rely on stem cell clones expressing transactivators (tTA or rtTA), limiting their broad applicability.

Purpose of the Study:

  • To develop an all-in-one lentiviral vector (LV) system for tight, inducible transgene expression in human stem cells using the native TetR repressor.
  • To engineer a robust system that overcomes the limitations of current technologies for conditional gene regulation in stem cells.

Main Methods:

  • Construction of Tet-On all-in-one lentiviral vectors (LVs) termed Lent-On-Plus.
  • Utilized specific promoter combinations and the Is2 insulator to shield the LVs.
  • Tested the system in human multipotent and pluripotent stem cells, assessing transgene regulation, long-term culture stability, and differentiation potential.

Main Results:

  • The Lent-On-Plus system achieved efficient and tight transgene regulation in bulk populations of human multipotent and pluripotent stem cells.
  • Generation of inducible stem cell lines did not require selection or cloning.
  • Stable transgene regulation was maintained throughout long-term culture and upon differentiation into various lineages.

Conclusions:

  • Lent-On-Plus represents the first all-in-one vector system for tightly regulated transgene expression in bulk human pluripotent stem cells and their progeny.
  • This system offers a significant advancement for gene therapy and stem cell research, enabling precise genetic manipulation.
  • The technology facilitates the generation of inducible stem cell lines without the need for laborious selection or cloning processes.

Related Concept Videos